A long-term developer of companies with ambitious science and the ability to tackle major medical challenges

October 15, 2021:
Flerie Invest leads $52m acquisition of Swedish Biopharma Facility from Charles River forming a new entity, NorthX Biologics (NXbio).

Portfolio

Flerie invests in venture and growth stage companies engaged in drug development and associated tools or applications tackling major medical challenges of our time

current investments

former investments

we invest

in people

We pride ourselves in being long-term people builders and we expect superior achievements in return

OUR TEAM ALL HAVE OPERATIONAL EXPERIENCE RUNNING BIOTECH AND PHARMA BUSINESSES THEMSELVES

Based in Stockholm and London and with investments across the EU, UK, US and Israel, the beginnings of Flerie Invest started with Thomas Eldered, co-founder and builder of Recipharm, which within 25 years became the fifth largest pharma CDMO in the world...

Learning from peers in the same industry is a cornerstone in our philosophy and Flerie Invest has created fora to facilitate this

flerie

and peers

Portfolio peers exchange throughout the year and selected CEOs meet for a gathering in the wilderness

We have a deep network in the anglo-nordic pharma ecosystem and have a physical presence in Stockholm and London

Skeppsbron 16
SE-111 30 Stockholm
Sweden

2 Royal College St,
NW1 0NH, London,
United Kingdom